
AI for Science | GTC Live Washington, D.C. Chapter 4
NVIDIA AI Podcast
00:00
What Realistic Gains Should We Expect in Drug Timelines?
Mark Tessier-Levine cautions realistic expectations while noting examples of rapid transitions from project start to clinical trials.
Play episode from 29:20
Transcript


